Nikolaj Sørensen
Chief Executive Officer en OREXO AB .
Fortuna: 242 087 $ al 31/03/2024
Origen de la red de primer grado Nikolaj Sørensen.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
36
| Public Company | Pharmaceuticals: Major | 36 |
| Public Company | Medical Specialties | 14 | |
| Public Company | Pharmaceuticals: Major | 14 | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Nikolaj Sørensen a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| AEROCRINE AB | Electronic Equipment/Instruments | Director/Board Member Chairman Chief Executive Officer | |
| PULMONX CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director of Finance/CFO Director/Board Member Chairman | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree | |
| MEDIVIR AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Oxford | College/University | Graduate Degree Undergraduate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Director/Board Member Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| University of Cambridge | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
| Stockholm School of Economics | College/University | Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Stockholm | College/University | Masters Business Admin Undergraduate Degree | |
| CAMURUS AB | Pharmaceuticals: Major | General Counsel Director/Board Member | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| University of Lund | College/University | Graduate Degree Graduate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Director of Finance/CFO Corporate Officer/Principal | |
| VIVESTO AB | Pharmaceuticals: Generic | Director of Finance/CFO Director/Board Member | |
Kibion AB
 Kibion AB Medical SpecialtiesHealth Technology Kibion AB manufactures and distributes medical test and analytical instruments. It provides solutions for rapid urea breath tests for diagnosing the stomach ulcer bacterium Helicobacter pylori. The firm offers products such as Heliprobe System, Diabact Urea Breath Test, and Kibion Dynamic. The company was founded in 2005 and is headquartered in Uppsala, Sweden. | Medical Specialties | Chairman Chief Executive Officer | |
| BioCrine AB | Director/Board Member Director/Board Member | ||
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Gothenburg | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Undergraduate Degree Corporate Officer/Principal | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chief Executive Officer Private Equity Investor | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member Corporate Officer/Principal | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
 Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Med Universe AB
 Med Universe AB Internet Software/ServicesTechnology Services Med Universe AB provides online social networking services for doctors. Its services include software as a service, insights over time and multi-channel usage. The company was founded by Anna Omstedt Lindgren and Anna Norin in 2009 and is headquartered in Stockholm, Sweden. | Internet Software/Services | Director/Board Member Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director of Finance/CFO Director/Board Member Director/Board Member Chief Operating Officer | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Chairman Director/Board Member | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member | |
Cormorant Pharmaceuticals AB
 Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Founder | |
| CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member Director/Board Member | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Xellia Holdco A/S | Director/Board Member | ||
| ONCOZENGE AB | Pharmaceuticals: Major | Chairman Sales & Marketing Director of Finance/CFO |
Estadísticas
Internacional
| Suecia | 39 |
| Reino Unido | 5 |
| Dinamarca | 5 |
| Suiza | 3 |
| Estados Unidos | 3 |
Sectorial
| Health Technology | 27 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Finance | 5 |
| Electronic Technology | 2 |
Operativa
| Director/Board Member | 332 |
| Corporate Officer/Principal | 116 |
| Chairman | 87 |
| Independent Dir/Board Member | 80 |
| Chief Executive Officer | 57 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Nikolaj Sørensen
- Conexiones Empresas
